Public consultation on proposed amendments to the Poisons Standard - ACMS, ACCS & Joint ACMS-ACCS, JUNE 2024

Closed 22 May 2024

Opened 23 Apr 2024

Contact

Medicines Scheduling

1800 020 653

medicines.scheduling@health.gov.au

Feedback updated 19 Sep 2024

We asked

We asked: 

From 22 May 2024 to 23 April 2024, we sought submissions from the public on scheduling proposals referred to the June 2024 meetings of the Advisory Committees on Medicines and Chemicals Scheduling. Respondents were given the choice to indicate their support or opposition to the proposed amendments using survey buttons, with or without a written response.

You said

You said: 

We received a total of 8 submissions in response to the pre-meeting public notice for June 2024. The breakdown of the responses has been provided below: 

SILDENAFIL: A total of 4 votes were received for sildenafil, one in full support, one in partial support and 2 in opposition of the proposal. All submissions provided a written response.

ALLYL ESTERS: No votes were received for allyl esters.

GLYOXYLIC ACID: No votes were received for glyoxylic acid.

INTRAVENOUS POTASSIUM SALTS: A total of 3 votes were received for intravenous potassium salts, all in full support of the proposal. Of these submissions, 2 provided a written response.

SULFONAMIDES: A total of 1 vote was received for sulfonamides, which was in full support the proposal. The submission did not provide a written response.

We did

We did: 

The Delegate considered all submissions prior to making an interim decision on these proposals. The interim decisions on the proposed amendments to the Poisons Standard were published on 19 September 2024. 

Published responses

View submitted responses where consent has been given to publish the response.

Overview

Scheduling amendments referred to expert advisory committee

This consultation is for applications and delegate initiated proposals to amend the Poisons Standard. The scheduling amendments and any submissions received will be considered at the JUNE 2024 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).

The closing date for this consultation is close of business 22 MAY 2024. All submissions received by the deadline will be considered by the delegate before they make an interim decision.

The proposals under consultation are detailed in the public notice of June 2024.

Substances for which public comment is sought:
 

ACMS:

  • SILDENAFIL

ACCS:

  • ALLYL ESTERS
  • GLYOXYLIC ACID

Joint meeting of ACMS-ACCS:

  • INTRAVENOUS POTASSIUM SALTS
  • SULFONAMIDES

What happens next

All public submissions will be published on the TGA website at Public submissions on scheduling matters, unless marked confidential or indicated otherwise in the submission information (see Privacy and your Personal information).

Public submissions are an important part of the process for amending the Poison Standard, and are published on the TGA website using the consultation hub.  Submissions by the public may not reflect the views of the Department of Health and Aged Care or TGA.  Published submissions should not be taken as being endorsed by the Department or TGA.

Following consideration of public submissions received before the closing date and advice from the expert advisory committee/s, decisions on the proposed amendments are anticipated to be published as interim decisions on the TGA website: Scheduling delegate's interim decisions & invitations for further comment at a later date. 

Audiences

  • Consumers
  • State government agencies
  • Health professionals
  • General public
  • Industry
  • Sponsors
  • Manufacturers

Interests

  • Policy Development